Teng, Guangshuai
Zhou, Yuan
Zhang, Yuhui
Shang, Ke
Lan, Yanjie
Wei, Xiaojing
Dong, Fuqiang
Y. H. Lip, Gregory
Liu, Tong
Duan, Minghui
Bai, Jie
Funding for this research was provided by:
Key Project of Tianjin Public Health Project (25ZXWZSY00140)
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2022-I2M-2-003)
National Natural Science Foundation of China (82270148)
National Natural Science Foundation of China (82400173)
Enterprise Science and Technology Commissioner Program of Tianjin Municipal Bureau of Science and Technology (25YDTPJC00070)
Joint Funds of the Tianjin Natural Science Foundation (25JCLMJC01040)
Haihe Laboratory of Cell Ecosystem Innovation Fund (HH24KYZX0012)
Tianjin Key Medical Discipline Construction Project (TJYXZDXK-3-001A-3)
Article History
Received: 14 January 2026
Accepted: 12 August 2026
First Online: 22 August 2026
Declarations
Ethics approval and consent to participate: The protocol of this study was reviewed and approved by the Ethics Committee of the Second Hospital of Tianjin Medical University (KY2025K005) and the Ethics Committee of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (I-26PJ0483), and the study was conducted in strict accordance with the principles of the Declaration of Helsinki. For the retrospective analysis of clinical data, the ethics committees approved a waiver of informed consent. For the collection of peripheral blood samples and subsequent cell culture experiments, written informed consent was obtained from all participating patients at the Second Hospital of Tianjin Medical University.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.
Use of artificial intelligence: No AI tools were used in the preparation of this manuscript.